Full Alliance Group, Inc.'s (OTC:FAGI) Wholly Owned Subsidiary DynaMAXX Health, Inc. Launches PRiVIVE(TM) Topical Serum: A Revolutionary Solution for Cellular Rejuvenation and Dermal Health
Full Alliance Group, Inc.'s (OTC:FAGI) Wholly Owned Subsidiary DynaMAXX Health, Inc. Launches PRiVIVE(TM) Topical Serum: A Revolutionary Solution for Cellular Rejuvenation and Dermal Health
TAMPA, FL / ACCESSWIRE / June 18, 2024 / Full Alliance Group, Inc (OTC PINK:FAGI) is thrilled to announce the launch of PRiVIVE Topical Serum, a groundbreaking product designed to enhance cellular rejuvenation, collagen synthesis, dermal elasticity, and the relaxation of localized tissues. This unique and diverse formulation can be applied anywhere on the body, making it a versatile addition to anyone's skincare regimen.
全联集团(OTC PINK:FAGI)非常高兴地宣布推出PRiVIVE局部补水精华液,这是一款开创性的产品,旨在增强细胞再生、胶原蛋白合成、真皮弹性和局部组织松弛度。这种独特而多样化的配方可以在身体的任何地方使用,使它成为任何人护肤日常护理的多功能佳品。
Revolutionary Delivery Technology
革命性输送技术
PRiVIVE is formulated with a proprietary and clinically demonstrated self-contained delivery technology. This advanced system dramatically enhances the permeation and cellular utilization of active compounds, ensuring maximum efficacy. PRiVIVE also allows for the addition of unique additives such as Platelet-Rich Plasma (PRP) or Exosomes, further maximizing their transport and utilization for one-of-a-kind aesthetic and therapeutic results.
PRiVIVE采用专有的并且得到临床证实的自包含输送技术进行调配。这种先进的系统极大地增强了活性化合物的渗透和细胞利用率,确保最大的功效。并且PRiVIVE产品还可以添加独特的添加剂,如富含血小板的血浆(PRP)或外泌体,进一步提高它们的传输和利用效果,以达到独一无二的美容和疗效结果。
Transformative Additives for Enhanced Results
改变性添加剂以增强效果
One of the standout features of PRiVIVE is its compatibility with unique additives like Platelet-Rich Plasma (PRP) and Exosomes. PRP, derived from the patient's own blood, is rich in growth factors and has been shown to accelerate tissue repair and regeneration. When combined with PRiVIVE, the delivery technology ensures that PRP penetrates deeper into the skin, enhancing its rejuvenating effects and promoting faster healing and cellular turnover.
PRiVIVE最出色的特点之一是它与富含血小板的血浆(PRP)和外泌体等独特添加剂的兼容性。由患者自身血液提取的PRP富含生长因子,已被证明可以加速组织修复和再生。与PRiVIVE相结合,输送技术确保PRP更深层地渗透到皮肤中,增强其恢复效果,促进更快的愈合和细胞更新。
Similarly, Exosomes, which are extracellular vesicles known for their role in cell communication and regeneration, can be added to PRiVIVE. Exosomes are packed with proteins, lipids, and genetic material that can stimulate tissue repair and reduce inflammation. The advanced delivery system in PRiVIVE ensures these exosomes reach their target cells more effectively, leading to improved skin texture, elasticity, and overall appearance.
同样,PRiVIVE还可以添加外泌体。外泌体是一种细胞间通讯和再生中发挥作用的细胞外囊泡,充满蛋白质、脂质和基因物质,可以刺激组织修复,减轻炎症。PRiVIVE中先进的输送系统确保这些外泌体更有效地到达目标细胞,从而改善皮肤质地、弹性和整体外观。
Key Ingredients and Their Benefits
主要成分及其优点
Centella Asiatica (Gotu Kola)
穿心莲(Gotu Kola)
Promotes fibroblast proliferation
Increases collagen synthesis
Improves tensile strength of new skin
Supports proper healing following dermal injury
促进成纤维细胞增殖
促进胶原蛋白合成
提高新皮肤的拉伸强度
支持皮肤在真皮创伤后的适当愈合
PEA (Palmitoylethanolamide)
PEA(棕榈酰酰胺)
Stimulates the nuclear receptor (PPAR-a)
Regulates immune response and mast cell stability
Involved in skin homeostasis, barrier protection, hydration, and regeneration
Contributes to proper inflammatory metabolism
刺激核激素受体(PPAR-a)
调节免疫反应和肥大细胞稳定性
参与皮肤稳态、屏障保护、水合和再生
有利于适当的炎症代谢
Oligopeptide-1 (Epidermal Growth Factor)
寡肽-1(表皮生长因子)
Stimulates cell growth, healing, and differentiation
Boosts synthesis of collagen, elastin, and hyaluronic acid
促进细胞生长、愈合和分化
增加胶原蛋白、弹性蛋白和透明质酸的合成
Syn-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
Syn-Ake (二肽二氨基丁酰苄胺乙酸酯)
Synthetic tripeptide with molecular weight below 500 Da
分子量低于500 Da的合成三肽
Mimics Waglerin-1 functionality, a peptide found in the venom of the temple viper
Inhibits muscle contraction.
Reduces the appearance of deep wrinkles
模仿寺庙蝰蛇毒液中发现的Waglerin-1的功能的肽
抑制肌肉收缩。
减少深层皱纹的出现
Used as preventive, can delay progression of wrinkles associated with aging skin
Promotes relaxation via reduced muscle contraction, but does not affect facial expression
Potentially, local relaxation of muscles beneath the skin can improve local circulation
作为预防用,可以延缓与老化皮肤相关的皱纹的发展
通过减少肌肉收缩促进放松,但不影响面部表情
潜在地,皮肤下面的肌肉局部放松可以改善局部循环
Exclusive Availability Through Medical Professionals
通过医疗专业人士专属供应
PRiVIVE Topical Serum is available exclusively through medical professionals, ensuring that customers receive the highest quality product with expert guidance on its application and benefits. While DynaMAXX Health will offer PRiVIVE to other medical professionals, it will be primarily available through MAXX Health Clinics. These clinics are renowned for their commitment to providing advanced health solutions, making them the ideal partner for the launch of PRiVIVE.
PRiVIVE 保湿精华液仅通过医疗专业人士提供,确保客户获得高品质的产品,专业指导其应用和优点。然而,DynaMAXX Health 会向其他医疗专业人士提供PRiVIVE,主要通过MAXX Health Clinics提供。这些诊所以提供先进的健康解决方案而著称,是PRiVIVE推出的理想合作伙伴。
A Commitment to Excellence
承诺卓越
By offering PRiVIVE primarily through MAXX Health Clinics, Full Alliance Group reinforces its dedication to excellence and customer satisfaction. Patients can trust that they are receiving a product that has been rigorously tested and supported by clinical evidence, ensuring the best possible outcomes for their skin health and overall well-being. This selective distribution approach guarantees that PRiVIVE users receive the best care and guidance from trained medical professionals.
通过主要通过MAXX Health Clinics提供PRiVIVE,Full Alliance Group 强化了对卓越和客户满意度的承诺。患者可以信任他们收到已经通过严格测试和临床证明支持的产品,确保他们的皮肤健康和整体健康获得最佳结果。这种有选择的分销方式保证PRiVIVE用户从训练有素的医疗专业人员那里获得最好的护理和指导。
About Full Alliance Group, Inc.
关于全联盟集团,Inc。
Full Alliance Group, Inc. is a holding company in the health and wellness sector.
Full Alliance Group, Inc. 是一个健康和健康行业的控股公司。
FAGI's wholly owned subsidiary, Bio Lab Naturals, Inc., founded in 2000, through its FDA-registered wholly owned subsidiary Pure Solutions, Inc., was built on the simple principles of using the highest quality ingredients, producing products with the greatest possible efficacy, and providing its partners with unsurpassed customer service all at a fair price. From day one, the Company has specialized in custom product development and FDA-compliant contract manufacturing, with a passion for cutting-edge formulations and innovative product selection. Now housed in a state-of-the-art 25,000 square foot facility in Tampa, Pure Solutions remains committed to its founding principles and is ready to expand its operations through growing organically by adding diversity to its in-house product lines and strategically through joint ventures, partnerships, acquisitions, exclusive manufacturing and distribution agreements, and mergers.
FAGI 的全资子公司 Bio Lab Naturals, Inc. 成立于2000年,通过其FDA注册的全资子公司 Pure Solutions, Inc.,立足于使用最高质量的原料,生产具有最大可能功效的产品,并以公道的价格为合作伙伴提供无与伦比的客户服务。从成立的第一天起,公司就专门从事定制产品开发和符合FDA合规的合同制造,热衷于开发最前沿的配方和创新产品选择。现在,位于坦帕市 2.5万平方英尺的尖端设施 Pure Solutions 依然致力于其创立原则,并准备通过通过增加自有产品线的多样性和战略性地通过合资企业,合作伙伴关系,收购,独家制造和分销协议以及并购来扩大其业务。
FAGI's other wholly owned subsidiary DynaMAXX International Ltd. is in the health and supplement space using the direct selling channel as its sales force with its main operations in the United States and Canada. DynaMAXX was founded in 2009 and has expanded globally since that time with its line of supplements. In addition to having a world class supplement product line, in October 2023 DynaMAXX launched the first ever cash pay medical referral network through its independent reps ("Members"); allowing its members to refer friends, family, other Members and customers to doctors who participate in the DynaMAXX Health Network. Initially, DynaMAXX Health Inc. is referring patients for EBOO/EBO2, PRP, Shockwave procedures to doctors in the network. DynaMAXX has a cost-effective way for individuals to participate in the ever-growing GIG economy by offering an aggressive compensation program to those that refer customers who purchase products, refer individuals to the DynaMAXX Health Network or to other individuals who want to start their own business. The company offers training and support to their distributors and has a strong focus on helping people achieve financial freedom through their business opportunity.
FAGI 的另一家全资子公司 DynaMAXX International Ltd. 在健康和保健领域使用直销渠道作为其销售力量,在美国和加拿大有其主要业务。DynaMAXX 成立于2009年,自那时以来,已通过其补充产品线在全球范围内展开了扩张。除了拥有世界一流的补充品产品线外,在2023年10月,DynaMAXX 通过其独立代表("会员")推出了第一个现金支付医疗转介网络;允许其会员将朋友,家庭,其他会员和客户转介到参与DynaMAXX Health Network的医生。最初,DynaMAXX Health Inc.将患者转介给网络中的医生进行EBOO / EBO2,PRP,Shockwave手术。 DynaMAXX提供一种经济高效的方式,供个人参与不断增长的GIG经济,通过向购买产品的客户,将个体转介到DynaMAXX Health Network或希望开始自己的业务的其他个人提供激励性补贴计划。该公司为其分销商提供培训和支持,并专注于帮助人们通过其商业机会实现财务自由。
Fact Sheet:
事实表:
For media inquiries, please contact:
媒体垂询,请联系:
Contact: Samantha Brainerd, Director of Sales and Marketing DYNAMAXX
Email: sbrainerd@dynamaxx.com
Phone: (949)-212-8863
联系人:Samantha Brainerd,销售和市场总监DYNAMAXX
电子邮件:sbrainerd@dynamaxx.com
电话:(949)-212-8863
Full Alliance Group Inc. Investor Relations
全联盟集团股东关系
Contact: Gabe Rodriguez, Erelations Group
Email: Erelationsgroup@gmail.com
Phone: (623) 261-9046
联系人:Gabe Rodriguez,电子关系组
电子邮件:Erelationsgroup@gmail.com
电话:(623) 261-9046
Forward-Looking Statements
前瞻性声明
This shareholder update may contain forward-looking statements. Words and variations of words such as: "expect," "goals," "could," "plans," "believe," "continue," "may," "will," and similar expressions are intended to identify our forward-looking statements, including but not limited to our expectation for growth, benefits from brand-building, cost savings, and margins. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause our actual results to differ materially from those indicated in our forward-looking statements. Such factors include but are not limited to continued volatility of and sharp increase in costs/pricing actions, increased competition, ability to raise sufficient operating capital, risks from operating internationally, consumer weakness, weakness in economic conditions, and tax law changes.
这份股东更新可能包含前瞻性声明,包括但不限于对于我们预期的成长、品牌建设、成本节约和利润率的期望等。为了辨认这些前瞻性声明,我们使用“期望”、“目标”、“可能”、“计划”、“相信”、“继续”、“可能”、“将”等词汇及其变体。这些前瞻性声明存在多种风险和不确定性,其中许多因素超出了我们的控制范围,这可能会导致我们的实际结果与我们的前瞻性声明所示结果有所不同。这些因素包括但不限于成本/定价行动的持续波动和剧烈增加、竞争加剧、筹集足够的营运资本能力、国际经营的风险、消费弱势、经济条件的弱势和税法变更。
SOURCE: Full Alliance Group, Inc.
来源:全联盟集团股份有限公司
译文内容由第三方软件翻译。